Digital transformation of pharmaceutical companies in the conditions of import substitution

The article describes current approaches to the digital transformation of pharmaceutical companies, taking into account the specifics of the requirements of import substitution of software for domestic production systems. Based on publications and open sources of information, the most relevant solutions were selected for the implementation of ERP systems, business analytics, cloud infrastructure, work with big data, the Internet of Things, for robotic automation of processes based on machine learning and artificial intelligence. These systems are analyzed from the point of view of their applicability in the framework of the digital transformation of pharmaceutical companies. Their brief characteristics are given and the purpose is described. The research of the software market showed the availability of affordable solutions of domestic development that can be implemented at a pharmaceutical enterprise to carry out work within the framework of the digital transformation of business processes.